ghk cu clinical trials results january 2026 Biological efficacy of GHK-Cu after ionic-liquid loading. (a) Cellular Copper, Collagen, and Controversy: Inside
Description
9 The researchers also noted that sublingual B12 has many practical advantages over injections, which are painful, costly, and require repeated clinic visits
Conflicts of Interest The authors declare that they have no conflict of interest
In the SURMOUNT-1 trial with 2,539 adults with obesity, participants on the highest tirzepatide dose (15 mg weekly) lost an average of 20.9% of their body weight over 72 weeks
If you're a member of the FB group 'pernicious anaemia/B12 deficiency', theres a link on their files page which will take you direct to the B12 product
Beyond GI effects, clinical trials documented dose-dependent heart rate increases that peaked at approximately 24 weeks and then declined
